Skip to main content
Premium Trial:

Request an Annual Quote

NRGene, RCK Partner to Develop Medical Cannabis DNA Biomarkers

NEW YORK (GenomeWeb) — NRGene said today that it has partnered with Israeli cannabis production company RCK to develop DNA-based biomarkers for medical cannabis breeding and strain identification.

Under the terms of the deal, the partners will use NRGene's computational tools to develop the biomarkers for commercial use. Additional terms were not disclosed.

"Today, no reliable method exists to distinguish among cannabis strains, so the quality and purity of the produced material is uncertain," RCK Chief Technology Officer Noam Chehanovsky said in a statement. "As the plant is grown for medical treatment, and different strains are used to treat different medical conditions, it is crucial we ensure the strain's identity, [and the] quality and efficacy of every batch of the medical cannabis produced."

Earlier this year, Syngenta licensed NRGene's GenoMagic cloud-based genome analysis platform for use in crop molecular breeding and genomic selection. Ness Ziona, Israel-based NRGene also has formed agricultural partnerships for its genome assembly and analysis technologies with Illumina and Monsanto.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.